-+ 0.00%
-+ 0.00%
-+ 0.00%

Evercore ISI Group Initiates Coverage On vTv Therapeutics with Outperform Rating, Announces Price Target of $44

Benzinga·03/12/2026 11:08:36
Listen to the news
Evercore ISI Group analyst Michael DiFiore initiates coverage on vTv Therapeutics (NASDAQ:VTVT) with a Outperform rating and announces Price Target of $44.